152 related articles for article (PubMed ID: 34371149)
1. Hot-melt extrusion based sustained release ibrutinib delivery system: An inhibitor of Bruton's Tyrosine Kinase (BTK).
Alshahrouri B; Yang F; Schwing Q; Dürig T; Fassihi R
Int J Pharm; 2021 Sep; 607():120981. PubMed ID: 34371149
[TBL] [Abstract][Full Text] [Related]
2. The Preparation of Curcumin Sustained-Release Solid Dispersion by Hot-Melt Extrusion-Ⅱ. Optimization of Preparation Process and Evaluation In Vitro and In Vivo.
Fan W; Zhang X; Zhu W; Di L
J Pharm Sci; 2020 Mar; 109(3):1253-1260. PubMed ID: 31794699
[TBL] [Abstract][Full Text] [Related]
3. Hot Melt Extrusion: Development of an Amorphous Solid Dispersion for an Insoluble Drug from Mini-scale to Clinical Scale.
Agrawal AM; Dudhedia MS; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):133-47. PubMed ID: 26729533
[TBL] [Abstract][Full Text] [Related]
4. Sustained-Release Solid Dispersion of High-Melting-Point and Insoluble Resveratrol Prepared through Hot Melt Extrusion to Improve Its Solubility and Bioavailability.
Zhu W; Fan W; Zhang X; Gao M
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443569
[TBL] [Abstract][Full Text] [Related]
5. Five-Stage Approach for a Systematic Screening and Development of Etravirine Amorphous Solid Dispersions by Hot-Melt Extrusion.
Simões MF; Pereira A; Cardoso S; Cadonau S; Werner K; Pinto RMA; Simões S
Mol Pharm; 2020 Feb; 17(2):554-568. PubMed ID: 31774685
[TBL] [Abstract][Full Text] [Related]
6. The Preparation of Curcumin Sustained-Release Solid Dispersion by Hot Melt Extrusion-Ⅰ. Optimization of the Formulation.
Fan W; Zhu W; Zhang X; Di L
J Pharm Sci; 2020 Mar; 109(3):1242-1252. PubMed ID: 31809744
[TBL] [Abstract][Full Text] [Related]
7. Preparation and Characterization of pH-Independent Sustained-Release Tablets Containing Hot Melt Extruded Solid Dispersions of Clarithromycin : Tablets Containing Solid Dispersions of Clarithromycin.
Ijaz QA; Latif S; Shoaib QU; Rashid M; Arshad MS; Hussain A; Bukhari NI; Riaz S; Abbas N
AAPS PharmSciTech; 2021 Nov; 22(8):275. PubMed ID: 34773162
[TBL] [Abstract][Full Text] [Related]
8. Rheology Guided Rational Selection of Processing Temperature To Prepare Copovidone-Nifedipine Amorphous Solid Dispersions via Hot Melt Extrusion (HME).
Yang F; Su Y; Zhang J; DiNunzio J; Leone A; Huang C; Brown CD
Mol Pharm; 2016 Oct; 13(10):3494-3505. PubMed ID: 27602878
[TBL] [Abstract][Full Text] [Related]
9. Hot-melt extrudability of amorphous solid dispersions of flubendazole-copovidone: An exploratory study of the effect of drug loading and the balance of adjuvants on extrudability and dissolution.
de Assis JMC; Barbosa EJ; Bezzon VDN; Lourenço FR; Carvalho FMS; Matos JR; Araci Bou-Chacra N; Benmore CJ; Byrn SR; Costa FN; de Araujo GLB
Int J Pharm; 2022 Feb; 614():121456. PubMed ID: 35017024
[TBL] [Abstract][Full Text] [Related]
10. Ibrutinib amorphous solid dispersions with enhanced dissolution at colonic pH for the localized treatment of colorectal cancer.
Patel H; Palekar S; Patel A; Patel K
Int J Pharm; 2023 Jun; 641():123056. PubMed ID: 37207861
[TBL] [Abstract][Full Text] [Related]
11. Chrono modulated multiple unit particulate systems (MUPS) via a continuous hot melt double extrusion technique: Investigation of the formulation and process suitability.
Kallakunta VR; Sarabu S; Dudhipala N; Janga KY; Bandari S; Zhang F; Repka MA
Eur J Pharm Biopharm; 2021 Nov; 168():184-194. PubMed ID: 34464695
[TBL] [Abstract][Full Text] [Related]
12. Strategies to improve the stability of amorphous solid dispersions in view of the hot melt extrusion (HME) method.
Al-Japairai K; Hamed Almurisi S; Mahmood S; Madheswaran T; Chatterjee B; Sri P; Azra Binti Ahmad Mazlan N; Al Hagbani T; Alheibshy F
Int J Pharm; 2023 Nov; 647():123536. PubMed ID: 37865133
[TBL] [Abstract][Full Text] [Related]
13. Development of novel darunavir amorphous solid dispersions with mesoporous carriers.
Zolotov SA; Demina NB; Zolotova AS; Shevlyagina NV; Buzanov GA; Retivov VM; Kozhukhova EI; Zakhoda OY; Dain IA; Filatov AR; Cheremisin AM
Eur J Pharm Sci; 2021 Apr; 159():105700. PubMed ID: 33429047
[TBL] [Abstract][Full Text] [Related]
14. Drug-Smectite Clay Amorphous Solid Dispersions Processed by Hot Melt Extrusion.
Nandi U; Mithu MSH; Hurt AP; Trivedi V; Douroumis D
AAPS PharmSciTech; 2020 Oct; 21(7):276. PubMed ID: 33033890
[TBL] [Abstract][Full Text] [Related]
15. Lacidipine Amorphous Solid Dispersion Based on Hot Melt Extrusion: Good Miscibility, Enhanced Dissolution, and Favorable Stability.
Xi L; Song H; Wang Y; Gao H; Fu Q
AAPS PharmSciTech; 2018 Oct; 19(7):3076-3084. PubMed ID: 30094722
[TBL] [Abstract][Full Text] [Related]
16. Hot melt extruded Aprepitant-Soluplus solid dispersion: preformulation considerations, stability and in vitro study.
Penumetcha SS; Gutta LN; Dhanala H; Yamili S; Challa S; Rudraraju S; Rudraraju S; Rudraraju V
Drug Dev Ind Pharm; 2016 Oct; 42(10):1609-20. PubMed ID: 26925514
[TBL] [Abstract][Full Text] [Related]
17. Amorphous solid dispersions of cyclosporine A with improved bioavailability prepared via hot melt extrusion: Formulation, physicochemical characterization, and in vivo evaluation.
Jiang X; Zhao Y; Guan Q; Xiao S; Dong W; Lian S; Zhang H; Liu M; Wang Z; Han J
Eur J Pharm Sci; 2022 Jan; 168():106036. PubMed ID: 34637896
[TBL] [Abstract][Full Text] [Related]
18. Amorphous-based controlled-release gliclazide matrix system.
Lu Z; Yang Y; Covington RA; Bi YV; Dürig T; Fassihi R
AAPS PharmSciTech; 2017 Jul; 18(5):1699-1709. PubMed ID: 27714702
[TBL] [Abstract][Full Text] [Related]
19. Reactive Melt Extrusion To Improve the Dissolution Performance and Physical Stability of Naproxen Amorphous Solid Dispersions.
Liu X; Zhou L; Zhang F
Mol Pharm; 2017 Mar; 14(3):658-673. PubMed ID: 28135108
[TBL] [Abstract][Full Text] [Related]
20. Supersaturated controlled release matrix using amorphous dispersions of glipizide.
Lu Z; Yang Y; Covington RA; Bi YV; Dürig T; Ilies MA; Fassihi R
Int J Pharm; 2016 Sep; 511(2):957-68. PubMed ID: 27492020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
